EUVIMEDEUVIMED entdecken
Crossref

Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment

Telal Dogruel, Pinar Kadirogullari, Hikmet Can Dogruel, Umran Karabulut Dogan, Erhan Huseyin Comert, Ozan Dogan

International Urogynecology Journal · 2026-10 · 37 (10) · 3233-3240

DOI: 10.1007/s00192-026-06687-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urogynecology Journal, online erschienen am 16.05.2026. Verfasst von Telal Dogruel und 5 weiteren Autor:innen. Beteiligte Einrichtung: VM Medical Park Maltepe Hospital Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Istanbul, Turke…. Hauptthemen laut MEDLINE: Lasers, Gas, Female Urogenital Diseases. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND HYPOTHESIS: To evaluate the short- and long-term clinical outcomes of fractional CO2 laser therapy in postmenopausal women with genitourinary syndrome of menopause (GSM), including durability of symptom control and the need for booster sessions. METHODS: This retrospective single-center study included 126 postmenopausal women with GSM who underwent a standardized three-session fractional CO2 laser protocol. Booster sessions were applied in cases of symptom recurrence. Outcomes were assessed at baseline, 4-6 weeks, 1 year, and 2 years using validated instruments: Patient Satisfaction Score, Michigan Incontinence Severity Index (MISI), Female Sexual Function Index (FSFI) and its subdomains, Vulvovaginal Symptoms Questionnaire (VSQ), and Female Genital Self-Image Scale (FGSIS). RESULTS: Significant improvement was observed in all outcome measures at 4-6 weeks, including GSM-related symptoms, sexual function, and genital self-image (all p < 0.0001). These benefits were largely sustained at 1 year. Although a slight decline was noted at 2 years, scores remained significantly improved compared to baseline. For example, FSFI lubrication scores improved from 2.97 ± 0.55 at baseline to 4.54 ± 0.49 at 1 year, and both VSQ and FGSIS demonstrated persistent gains at 2 years. Satisfaction scores continued to increase over time. Post hoc analyses confirmed significant differences across all evaluation time points. CONCLUSION: Fractional CO2 laser therapy provides clinically meaningful and durable improvement in GSM-related symptoms in postmenopausal women. While some decline may occur over time, benefits remain superior to baseline, and booster sessions may support long-term maintenance. Fractional CO2 laser may represent a nonhormonal, symptom-oriented option for carefully selected patients with GSM; however, it should not be considered first-line therapy, and prospective controlled studies are needed to further define long-term efficacy and patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, GasFemale Urogenital DiseasesHumansFemaleRetrospective StudiesMiddle AgedTreatment OutcomeSyndromePatient SatisfactionAgedPostmenopauseMenopause

Stichwörter der Autor:innen

Atrophic vaginitisCarbon dioxide laserGenitourinary syndrome of menopauseLaser therapyMenopauseVaginal mucosa

Autor:innen und Institutionen

  • VM Medical Park Maltepe Hospital Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Women's Health Clinic, Istanbul, Turkey. pinarsezer33@hotmail.com.
  • Department of Plastic, Reconstructive and Aesthetic Surgery, Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Acıbadem Kayseri Hospital, Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), Women's Health Clinic, Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, Women's Health Clinic, Pelvic Floor and Cosmetic Gynecology Association (PET-KOZ), İstanbul Nişantası University, Istanbul, Turkey.

Zitieren

APA

Dogruel, T., Kadirogullari, P., Dogruel, H. C., Dogan, U. K., Comert, E. H., & Dogan, O. (2026). Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment. International Urogynecology Journal, 37(10), 3233-3240. https://doi.org/10.1007/s00192-026-06687-4

Vancouver

Dogruel T, Kadirogullari P, Dogruel HC, Dogan UK, Comert EH, Dogan O. Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment. International Urogynecology Journal. 2026;37(10):3233-3240. doi:10.1007/s00192-026-06687-4

BibTeX
@article{Dogruel2026,
  author = {Dogruel, Telal and Kadirogullari, Pinar and Dogruel, Hikmet Can and Dogan, Umran Karabulut and Comert, Erhan Huseyin and Dogan, Ozan},
  title = {Two-Year Real-World Outcomes in Women with Genitourinary Syndrome of Menopause Following Fractional CO2 Laser Treatment},
  journal = {International Urogynecology Journal},
  year = {2026},
  volume = {37},
  number = {10},
  pages = {3233--3240},
  doi = {10.1007/s00192-026-06687-4}
}
Kostenlos starten →